Product Information

EMZAHH 0.35 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0982 per EA under NDC 59651013688. Its NADAC has been published 116 times since Aug 28, 2024.

FDA first approved this application on Jan 6, 2023. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EMZAHH 0.35 MG TABLET

NORETHINDRONE
$0.0982per EA

Strength

.35 mg/1

NDC

59651013688

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

NORETHINDRONE

Approval Type

Generic (ANDA)

FDA Application

ANDA216796

FDA Approved

1/6/2023

TE Code

AB2

On Market Since

1/6/2023

Pharmacological Classes

Progesterone Congeners
Progestin

Price Statistics

The NADAC for EMZAHH 0.35 MG TABLET has been published 116 times since Aug 28, 2024, and over the history we have for it it has declined 9.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0982 per EA
All-time high$0.1082 (Sep 11, 2024)
All-time low$0.0691 (Nov 20, 2024)
52-week high$0.0982
52-week low$0.0849
Median price$0.0902
Average price$0.0902
Largest weekly change-22.8% (Nov 20, 2024)
Weeks tracked116
Tracking sinceAug 28, 2024

Price History

1W

0.0%

1M

+6.2%

3M

+5.4%

6M

+6.4%

1Y

+9.0%

3Y

N/A

5Y

N/A

All

-9.3%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EMZAHH 0.35 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EMZAHH 0.35 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0982 per EA (NDC 59651013688), effective Nov 11, 2026.

How has the price of EMZAHH 0.35 MG TABLET changed over time?

Over the history we have for it, the NADAC for EMZAHH 0.35 MG TABLET has declined 9.3%. It has been tracked across 116 weekly CMS publications since Aug 28, 2024.

What are the highest and lowest recorded NADAC prices for EMZAHH 0.35 MG TABLET?

Since Aug 28, 2024, the NADAC for EMZAHH 0.35 MG TABLET has ranged from a low of $0.0691 (Nov 20, 2024) to a high of $0.1082 (Sep 11, 2024), with a median of $0.0902 per EA.

Are there cheaper alternatives to EMZAHH 0.35 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CAMILA 0.35 MG TABLET, is $0.0906 per EA — about 8% below EMZAHH 0.35 MG TABLET.

Who manufactures EMZAHH 0.35 MG TABLET?

EMZAHH 0.35 MG TABLET (NDC 59651013688) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.